Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T Helper Cell Subsets in Clinical Manifestations of Psoriasis
Marco Diani, G. F. Altomare, Eva Reali
Journal of Immunology Research (2016) Vol. 2016, pp. 1-7
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation
Ruifang Wu, Jinrong Zeng, Jin Yuan, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 6, pp. 2551-2568
Open Access | Times Cited: 231
Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation—Lessons From Rheumatoid Arthritis
Karine Chemin, Christina Gerstner, Vivianne Malmström
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 189
Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases
Qi Jiang, Guocan Yang, Fan Xiao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 105
Advances in Understanding the Immunological Pathways in Psoriasis
Simona Roxana Georgescu, Mircea Tampa, Constantin Căruntu, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 739-739
Open Access | Times Cited: 132
Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
Alessio Mylonas, Curdin Conrad
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 127
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis
Natasha Irrera, Mario Vaccaro, Alessandra Bitto, et al.
Clinical Science (2017) Vol. 131, Iss. 6, pp. 487-498
Closed Access | Times Cited: 123
GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis
Xichun Xia, Guangchao Cao, Guodong Sun, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5180-5196
Open Access | Times Cited: 81
The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics
Demetra S.M. Chatzileontiadou, Hannah Sloane, Andrea Nguyen, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 73-73
Open Access | Times Cited: 73
From Empirical to Pathogenesis-Based Treatments for Psoriasis
P.C.M. van de Kerkhof
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 7, pp. 1778-1785
Open Access | Times Cited: 54
Update on the etiopathogenesis of psoriasis (Review)
D Brănişteanu, Catalina Cojocaru, Roxana Diaconu, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 53
IL-33/ST2 axis in autoimmune disease
Leila Shakerian, Hanieh Kolahdooz, M Talebkhan Garousi, et al.
Cytokine (2022) Vol. 158, pp. 156015-156015
Closed Access | Times Cited: 50
The promise of precision medicine in rheumatology
Joel M. Guthridge, Catriona A. Wagner, Judith A. James
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1363-1371
Open Access | Times Cited: 43
Ameliorated Skin Inflammation through the Synergistic Effect of Gold Nanorod–Dexamethasone and Photothermal Therapy
Nam-Kyung Kim, Yong‐Gyu Jeong, Soyoung Lee, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 10, pp. 12217-12231
Closed Access | Times Cited: 8
Amlexanox ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting Th17 cells and the NF-κB signal pathway
Juan Wu, Shan Liu, Hongwei Zhang, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117922-117922
Open Access | Times Cited: 1
Environmental risk factors and epigenetic alternations in psoriasis
Marek Roszkiewicz, Klaudia Dopytalska, Elżbieta Szymańska, et al.
Annals of Agricultural and Environmental Medicine (2019) Vol. 27, Iss. 3, pp. 335-342
Open Access | Times Cited: 69
T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
Fabio Casciano, P. D. Pigatto, Paola Secchiero, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 62
Homocysteine and psoriasis
Xiran Lin, Xianmin Meng, Zhiqi Song
Bioscience Reports (2019) Vol. 39, Iss. 11
Open Access | Times Cited: 61
Potential Role of Probiotics in Ameliorating Psoriasis by Modulating Gut Microbiota in Imiquimod-Induced Psoriasis-Like Mice
Wenwei Lu, Yadan Deng, Zhifeng Fang, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 2010-2010
Open Access | Times Cited: 49
High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property
Brian Hyohyoung Lee, Yoon Ji Bang, Sung Ha Lim, et al.
EBioMedicine (2024) Vol. 100, pp. 104985-104985
Open Access | Times Cited: 6
Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis
Marco Diani, Fabio Casciano, Laura Marongiu, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Gene Expression Profiling in Behcet’s Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy
Antonio Puccetti, Piera Filomena Fiore, Andrea Pelosi, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-18
Open Access | Times Cited: 50
Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice
Yongliang Li, Zhiyun Du, Penghui Li, et al.
International Immunopharmacology (2018) Vol. 64, pp. 319-325
Closed Access | Times Cited: 50
Immunological Memory of Psoriatic Lesions
Agnieszka Owczarczyk‐Saczonek, Magdalena Krajewska–Włodarczyk, Marta Kasprowicz‐Furmańczyk, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 625-625
Open Access | Times Cited: 46
Drug delivery systems for the treatment of psoriasis: Current status and prospects
S.L. Jyothi, K.L. Krishna, V.K. Ameena Shirin, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 62, pp. 102364-102364
Closed Access | Times Cited: 38
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
Humzah Jamshaid, Fakhar ud Din, Maimoona Malik, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top